Perkembangan Sel Limfosit B Dan Penandanya Untuk Flowcytometry

Yelvi Levani(1*)


(1) FK UMSurabaya, Surabaya, East Java, Indonesia
(*) Corresponding Author

Abstract


B Cell Lymphocyte Development And Its Marker For Flowcytometry

 

Sel limfosit B merupakan bagian dari respon imunitas adaptif yang berperan penting untuk pertahanan tubuh melawan patogen. Perkembangan sel limfosit B dimulai dari sel punca hematopoietik di sumsum tulang belakang dan organ limfoid sekunder dengan melalui berbagai tahapan proses maturasi dan seleksi. Sel limfosit B matur dapat menghasilkan berbagai macam antibodi yang spesifik untuk patogen. Di tiap perkembangannya, sel limfosit B memiliki ekspresi molekul yang berbeda pada permukaannya dan dapat diketahui dengan pemeriksaan flowcytometry. Pemeriksaan sel limfosit B yang sesuai dengan tahapan perkembangannya dapat digunakan untuk membantu diagnosis penyakit defisiensi imun kongenital, leukemia, limfoma dan penyakit autoimun.

 

B lymphocyte cells are part of the adaptive immune response that plays an important role in the body's defense against pathogens. The development of B lymphocyte cells starts from hematopoietic stem cells in the spinal cord and secondary lymphoid organs through various stages of the maturation and selection process. Mature B lymphocyte cells can produce a variety of antibodies that are specific for pathogens. In each development, B lymphocyte cells have different molecular expressions on their surface and can be identified by flowcytometry examination. Examination of B lymphocyte cells according to their stage of development can be used to help diagnose congenital immune deficiency diseases, leukemia, lymphoma and autoimmune disease.




Keywords


Limfosit B; perkembangan; penanda; flowcytometry

Full Text:

PDF

References


Pieper K, Grimbacher B, Eibel H. B cell biology and development. J Allergy Clin Immunol 2013;131(4):959-71.

Todd I,Spickett G, Fairclough L. The nature of immune system. In: Todd I,Spickett G, Fairclough L. Immunology Lectures Note. 7thedition. West Sussex, Wiley Blackwell. 2015. p: 3-12.

LeBien TW, Tedder TF. B lymphocytes: How they develop and function. Blood. 2008;112: 1570-1580

van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigeninduced B cell expansion. J Exp Med 2007;204:645-55.

Matthias P, Rolink AG. Transcriptional networks in developing and mature B cells. Nat Rev Immunol 2005;5:497-508

Conley ME, Mathias D, Treadaway J, Minegishi Y, Rohrer J. Mutations in btk in patients with presumed X-linked agammaglobulinemia. Am J Hum Genet 1998; 62:1034-43.

Ponader S, Chen SS, Buggy JJ, Balakrishnan K, Gandhi V, Wierda WG, et al. The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood 2012;119:1182-9

Hutcheson J, Vanarsa K, Bashmakov A, Grewal S, Sajitharan D, Chang BY, et al. Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus. Arthritis Res Ther 2012; 14:R243.

Chung JB, Silverman M, Monroe JG. Transitional B cells: step by step towards immune competence. Trends Immunol. 2003;24:343-349

Marshall-Clarke S, Tasker L, Parkhouse RME. Immature B lymphocytes from adult bone marrow exhibit a selective defect in induce hyperexpression of major histocompatibility complex class II and fail to show B2.7 induction. Immunol. 2000;100(2):141-151.

Balazs M, Martin F, Zhou T, Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002;17:341-52. 12.Muramatsu M, Kinoshita K, Fagarasan S,Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102:553-563

Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000;102:565-75.

Allman D, Pillai S. Peripheral B subset. Curr Opin Immunol. 2008;20(2):149-157.

Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity. 2005;23:7-18.

Adan A, Alizada G, Kiraz Y, Baran Y, Nalbant A. Flow cytometry: basic principles and applications. Crit Rev Biotechnol. 2017;37(2):163-176.


Article Metrics

Abstract view : 15251 times
PDF - 3336 times

DOI: https://doi.org/10.26714/magnamed.1.5.2018.50-57

Refbacks

  • There are currently no refbacks.




Indexed by

 

      

 

Creative Commons License

MAGNA MEDIKA by APKKM is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.